Recurrent epigenetic alterations in SHH-activated medulloblastoma have been described in MLL2/KMT2D and MLL3/KMT2C, two lysine methyltransferases associated with an active chromatin state and the H3K4me2/3 status [8,32,33]. This evidence concerns the gene KMT2C and medulloblastoma.